Researcher in gene therapy and molecular biology. She holds a PhD in Human and Experimental Pathology from UFBA, in partnership with FIOCRUZ, a master’s in Biochemistry from the Université d’Abomey-Calavi (Benin), and a specialization in Epidemiology Applied to SUS Services from Fiocruz. Her scientific career has evolved from studying severe anemia in malaria to the identification of stroke risk biomarkers in patients with sickle cell anemia. She is currently developing CRISPR-based gene-editing strategies, focusing on the reactivation of fetal hemoglobin in hematopoietic stem cells for the treatment of hemoglobinopathies. She has also worked with induced pluripotent stem cells.
